In silico drug repositioning: from large-scale transcriptome data to therapeutics
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics
OS Kwon, WK Kim, HJ Cha… - Archives of Pharmacal …, 2019 - oldkmbase.medric.or.kr
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics.
OS Kwon, W Kim, HJ Cha, H Lee - Archives of Pharmacal Research, 2019 - europepmc.org
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
[PDF][PDF] In silico drug repositioning: from large-scale transcriptome data to therapeutics
OS Kwon, W Kim, HJ Cha, H Lee - 2019 - researchgate.net
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics
OS Kwon, W Kim, HJ Cha, H Lee - Archives of Pharmacal …, 2019 - pure.ewha.ac.kr
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics.
OS Kwon, W Kim, HJ Cha… - Archives of Pharmacal …, 2019 - search.ebscohost.com
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics
OS Kwon, W Kim, HJ Cha… - Archives of pharmacal …, 2019 - pubmed.ncbi.nlm.nih.gov
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
In silico drug repositioning: from large-scale transcriptome data to therapeutics
OS Kwon, WK Kim, HJ Cha… - Archives of Pharmacal …, 2019 - oldkmbase.medric.or.kr
Drug repositioning is an attractive alternative to conventional drug development when new
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …
beneficial effects of old drugs are clinically validated because pharmacokinetic and safety …